Clinical Trial

The Efficacy of Lymph Node Dissection for Stage IIICr of Cervical Cancer(CQGOG0103)

Recruiting
View on ClinicalTrials.gov →
Summary
This is an national, prospective, multicenter and randomized clinical study designed to determine if patients with stage IIICr of cervical cancer have longer PFS and/or OS with lymph node dissection before CCRT when compared to CCRT.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2020-09-14; most recent amendment 2025-08-25.
Trial Details
NCT Number NCT04555226
Lead Sponsor Chongqing University Cancer Hospital
Collaborators: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Jiangxi Provincial Cancer Hospital, Anhui Provincial Cancer Hospital, The Second Affiliated Hospital of Harbin Medical University, Hebei Medical University Fourth Hospital, Zhejiang Cancer Hospital, Women's Hospital School Of Medicine Zhejiang University, Qilu Hospital of Shandong University, Fujian Cancer Hospital, Sichuan Cancer Hospital and Research Institute, Cancer Hospital of Guizhou Province, West China Second University Hospital, Tongji Hospital, The Affiliated Ganzhou Hospital of Nanchang University, First Affiliated Hospital of Gannan Medical University, Gansu Provincial Maternal and Child Health Care Hospital, Third Affiliated Hospital of Xinjiang Medical University, Affiliated Cancer Hospital of Shantou University Medical College, Obstetrics & Gynecology Hospital of Fudan University, The Second Affiliated Hospital of Dalian Medical University, Fujian Maternity and Child Health Hospital, Shandong Cancer Hospital and Institute, Sun Yat-Sen University Cancer Center
Conditions Cervical Cancer
Enrollment 452 participants
Start Date 2021-01-11
Primary Completion 2029-08 (estimated)
Study Completion 2032-08 (estimated)
Updated on ClinicalTrials.gov 2025-09-02